Vanderbilt University School of Medicine

Engelhardt, Brian G. , M.D.
Associate Professor of Medicine

Lab Url: N/A

Phone Number: 615 936-0381


Engelhardt, Brian's picture

Office Address   Mailing Address

2665 The Vanderbilt Clinic

2665 TVC 37232-5505

Das-Gupta, E, Greinix, H, Jacobs, R, Zhou, L, Savani, BN, Engelhardt, BG, Kassim, A, Worel, N, Knobler, R, Russell, N, Jagasia, M. Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: Impact on six month freedom from treatment failure. Haematologica, , , 2014.

Ragon, BK, Clifton, C, Chen, H, Savani, BN, Engelhardt, BG, Kassim, AA, Vaughan, LA, Lucid, C, Jagasia, M. Geographic distance is not associated with inferior outcome when using long-term transplant clinic strategy. Biol Blood Marrow Transplant, 20(1), 53-7, 2014.

Reddy, NM, Oluwole, O, Greer, JP, Engelhardt, BG, Jagasia, MH, Savani, BN. Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma. Exp Hematol, 42(1), 39-45, 2014.

Sengsayadeth, S, Savani, BN, Jagasia, M, Goodman, S, Greer, JP, Chen, H, Chinratanalab, W, Kassim, AA, Engelhardt, BG. Six-month freedom from treatment failure is an important end point for acute GVHD clinical trials. Bone Marrow Transplant, 49(2), 236-40, 2014.

Jagasia, M, Greinix, H, Robin, M, Das-Gupta, E, Jacobs, R, Savani, BN, Engelhardt, BG, Kassim, A, Worel, N, Knobler, R, Russell, N, Socie, G. Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis. Biol Blood Marrow Transplant, 19(7), 1129-33, 2013.

Vaughan, LA, Vu, M, Sengsayadeth, S, Lucid, C, Clifton, C, McCarty, K, Hagaman, D, Domm, J, Kassim, A, Chinratanalab, W, Goodman, S, Greer, J, Frangoul, H, Engelhardt, BG, Jagasia, M, Savani, BN. New allergies after cord blood transplantation. Cytotherapy, 15(10), 1259-65, 2013.

Weitkamp, JH, Koyama, T, Rock, MT, Correa, H, Goettel, JA, Matta, P, Oswald-Richter, K, Rosen, MJ, Engelhardt, BG, Moore, DJ, Polk, DB. Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. Gut, 62(1), 73-82, 2013.

Engelhardt, BG, Jagasia, SM, Crowe, JE, Griffith, ML, Savani, BN, Kassim, AA, Lu, P, Weitkamp, JH, Moore, DJ, Yoder, SM, Rock, MT, Jagasia, M. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood, 119(10), 2417-21, 2012.

Engelhardt, BG, Sengsayadeth, SM, Jagasia, M, Savani, BN, Kassim, AA, Lu, P, Shyr, Y, Yoder, SM, Rock, MT, Crowe, JE. Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival. Exp Hematol, 40(12), 974-982.e1, 2012.

Jacobs, R, Tran, U, Chen, H, Kassim, A, Engelhardt, BG, Greer, JP, Goodman, SG, Clifton, C, Lucid, C, Vaughan, LA, Savani, BN, Jagasia, M. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant, 47(11), 1470-3, 2012.

Jagasia, M, Clark, WB, Brown-Gentry, KD, Crawford, DC, Fan, KH, Chen, H, Kassim, A, Greer, JP, Engelhardt, BG, Savani, BN. Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant, 18(7), 1069-75, 2012.

Sengsayadeth, SM, Jagasia, M, Engelhardt, BG, Kassim, A, Strickland, SA, Goodman, S, Lucid, C, Vnencak-Jones, CL, Greer, JP, Savani, BN. Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. Bone Marrow Transplant, 47(12), 1535-7, 2012.

Clark, WB, Brown-Gentry, KD, Crawford, DC, Fan, KH, Snavely, J, Chen, H, Savani, BN, Kassim, A, Greer, JP, Schuening, FG, Engelhardt, BG, Jagasia, MH. Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD. Blood, 118(4), 1140-4, 2011.

Engelhardt, BG, Jagasia, M, Savani, BN, Bratcher, NL, Greer, JP, Jiang, A, Kassim, AA, Lu, P, Schuening, F, Yoder, SM, Rock, MT, Crowe, JE. Regulatory T cell expression of CLA or ??(4)??(7) and skin or gut acute GVHD outcomes. Bone Marrow Transplant, 46(3), 436-42, 2011.

Griffith, ML, Jagasia, MH, Misfeldt, AA, Chen, H, Engelhardt, BG, Kassim, A, Savani, BN, Survant, M, Jagasia, SM. Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation. Biol Blood Marrow Transplant, 17(1), 86-92, 2011.

Lucid, CE, Savani, BN, Engelhardt, BG, Shah, P, Clifton, C, Greenhut, SL, Vaughan, LA, Kassim, A, Schuening, F, Jagasia, M. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Bone Marrow Transplant, 46(3), 426-9, 2011.

Tedeschi, SK, Jagasia, M, Engelhardt, BG, Domm, J, Kassim, AA, Chinratanalab, W, Greenhut, SL, Goodman, S, Greer, JP, Schuening, F, Frangoul, H, Savani, BN. Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation. Cytotherapy, 13(1), 78-82, 2011.

Engelhardt, BG, Crowe, JE. Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells. Curr Top Microbiol Immunol, 341, 121-46, 2010.

Engelhardt, BG, Holland, DW, Brandt, SJ, Chinratanalab, W, Goodman, SA, Greer, JP, Jagasia, MH, Kassim, AA, Morgan, DS, Ruffner, KL, Schuening, FG, Wolff, S, Bitting, R, Sulur, P, Stein, RS. High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes. Leuk Lymphoma, 48(9), 1728-35, 2007.

Postdoctoral Position Available

Postdoctoral Position Details

Updated Date

Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Copyright 2008 Vanderbilt University School of Medicine
The office of Biomedical Research Education & Training All rights reserved.
For questions or problems concerning this page, please submit a help ticket.